Clinical Trials Logo

Cholestasis clinical trials

View clinical trials related to Cholestasis.

Filter by:

NCT ID: NCT01238900 Completed - Clinical trials for Benign Biliary Strictures

Evaluation of the Use of Metal Stents as Part of the Treatment of Benign Biliary Strictures

Start date: May 2009
Phase: N/A
Study type: Observational

The purpose of this study is to study the evaluation of the use of metal stents as part of the treatment of benign biliary strictures.

NCT ID: NCT01226823 Not yet recruiting - Clinical trials for Intrahepatic Cholestasis of Pregnancy

Ursodeoxycholic Acid And Cholestasis Of Pregnancy

CERTO
Start date: November 2010
Phase: Phase 3
Study type: Interventional

The study is a multicenter randomized double blind placebo controlled trial. The study will be conducted on pregnant women with a diagnosis of intrahepatic cholestasis of pregnancy (ICP) in third level hospitals (that are also Academic Hospitals). Pregnant women at the time of ICP diagnosis will be randomized in two groups: Group 1 - will receive placebo and obstetrical monitoring until delivery Group 2 - will receive UDCA at the dose of 20 mg/Kg/day and obstetrical monitoring until delivery. The hypotheses are that UDCA treatment will be superior to placebo and effective in: reducing the rate of prematurity; improving maternal biochemical parameters and symptoms.

NCT ID: NCT01194063 Completed - Cholestasis Clinical Trials

Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children

Start date: October 20, 2010
Phase: Phase 3
Study type: Interventional

Use of a fish oil emulsion to decrease liver disease due to long term intravenous nutrition.

NCT ID: NCT01173159 Completed - Cholestasis Clinical Trials

Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis

Start date: July 2010
Phase: N/A
Study type: Interventional

The purpose of this research study is to see if giving Omegaven (an intravenous fat emulsion containing fish oil) instead of the current lipid emulsion, which contains fat derived from soybeans, as part of your child's intravenous (IV) nutrition therapy may be tolerated better. It may reduce the harmful effects to the liver, may stop any further liver damage and may reverse damage already done to the liver because of the prolonged use of nutrition through your child's IV.

NCT ID: NCT01164878 Completed - Cholestasis Clinical Trials

Cholestasis in Extreme Low Birth Weight Infants (ELBW)

Start date: January 2010
Phase: N/A
Study type: Observational

Parenteral nutrition associated liver disease (PNALD) in preterm neonates is characterized by early occurrence of intrahepatic cholestasis (parenteral nutrition associated cholestasis (PNAC). Extreme low birth weight infants (ELBW, birth weight < 1000 g) are at increased risk for development of PNAC. Important factors implicated in the aetiology of PNAC are high caloric parenteral nutrition using amino acids or dextrose, but also intravenous lipids and infections in particular necrotizing enterocolitis (NEC). Due to a change of paradigm a more aggressive nutrition with early use of parenteral amino acids/lipids and early fortification of mothers milk or alternatively high caloric preterm formula is warranted. Accordingly - in line with the existing expert opinion and evidence - the feeding policy at the neonatal care units of our hospital was adapted. Evidence exists that PNAC might be caused by the use of high concentrations of amino acids and lipids in parenteral nutrition. Furthermore NEC is associated with high osmotic feeds. Therefore the incidence of PNAC might be increased directly and indirectly after introducing the new feeding policy. The investigators therefore aim at retrospectively investigating the incidence of PNAC before and after introduction of a feeding policy of "aggressive nutrition" for ELBW infants.

NCT ID: NCT01151280 Completed - Clinical trials for Anastomotic Biliary Stricture Post Orthotopic Liver Transplant

WallFlex Biliary Post Liver Transplant IDE Pilot

Start date: October 2009
Phase: N/A
Study type: Interventional

The primary objective of this study is to demonstrate effectiveness of the WallFlex Biliary RX Fully Covered Stent for anastomotic biliary strictures in post-orthotopic liver transplant (OLT) patients.

NCT ID: NCT01125865 Recruiting - Clinical trials for Bile Duct Obstruction

Uncovered Self-expandable Metal Stent Versus Double Layer Plastic Stent for Malignant Hilar Stricture

Start date: May 2010
Phase: Phase 4
Study type: Interventional

The overall median survival of nonresectable malignant hilar obstruction in most series has been less than 6 months. Most patients with malignant hilar obstruction present with advanced disease, making palliative endoscopic drainage the principal therapeutic option. However, the optimal endoscopic management strategy is contentious. Almost all of the published data comparing plastic and metallic stents relate to distal tumors (those of the pancreas, common bile duct and ampulla). Stent patency, complication rates, and cost-effectiveness have favored metallic stents when compared with plastic stents in patients with distal malignant obstruction expected to live at least 3 to 6 months. There are few comparative study as to whether self-expanding metallic or plastic stent, especially DLS (double layer plastic stent) are preferable in the technical success, stent patency, and cost-effectiveness for palliating malignant hilar obstruction. The study was designed to compare the the technical success, stent patency, and cost-effectiveness of self-expandable metal stent and DLS in patients with malignant hilar obstruction.

NCT ID: NCT01085747 Unknown status - Clinical trials for Chronic Pancreatitis

Endoscopic Treatment of Biliary Stricture Caused by Chronic Pancreatitis

Start date: March 2008
Phase: N/A
Study type: Observational

Benign biliary strictures can be endoscopically treated with plastic or self-expandable metal stents (SEMS). The purpose of the prospective randomized study is to compare the safety and feasibility of covered SEMS with multiple plastic stents in the treatment of benign biliary stricture caused by chronic pancreatitis.

NCT ID: NCT01082419 Completed - Liver Cirrhosis Clinical Trials

Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity

NARFI
Start date: April 2010
Phase: N/A
Study type: Interventional

Liver stiffness measurement (LSM) by non invasive methods is increasingly used to estimate liver fibrosis in patients with chronic liver diseases. However, there is growing evidence that fibrosis is not the only determinant of liver stiffness. Indeed inflammation, cholestasis, congestion could also interfere with stiffness measurements. Acoustic radiation force impulse imaging (ARFI) is a new technology to perform real time LSM. Using a standard ultrasonographic probe, it offers elastography with a flexible metering box at variable depth, allowing the examination of specific area.

NCT ID: NCT01073202 Completed - Clinical trials for Liver Transplantation

Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation

Start date: May 2005
Phase: N/A
Study type: Interventional

This study is designed to investigate the possible beneficial effects of UDCA on liver graft recovery early after adult liver transplantation.